21 CFR Subpart D
Clinical Toxicology Test Systems
June 25, 2020
§
862.3560
Lithium test system
§
862.3670
Phenothiazine test system
§
862.3030
Acetaminophen test system
§
862.3035
Amikacin test system
§
862.3040
Alcohol test system
§
862.3050
Breath-alcohol test system
§
862.3080
Breath nitric oxide test system
§
862.3100
Amphetamine test system
§
862.3110
Antimony test system
§
862.3120
Arsenic test system
§
862.3150
Barbiturate test system
§
862.3170
Benzodiazepine test system
§
862.3680
Primidone test system
§
862.3200
Clinical toxicology calibrator
§
862.3220
Carbon monoxide test system
§
862.3240
Cholinesterase test system
§
862.3250
Cocaine and cocaine metabolite test system
§
862.3270
Codeine test system
§
862.3280
Clinical toxicology control material
§
862.3300
Digitoxin test system
§
862.3320
Digoxin test system
§
862.3350
Diphenylhydantoin test system
§
862.3360
Drug metabolizing enzyme genotyping system
§
862.3380
Ethosuximide test system
§
862.3450
Gentamicin test system
§
862.3520
Kanamycin test system
§
862.3550
Lead test system
§
862.3555
Lidocaine test system
§
862.3580
Lysergic acid diethylamide (LSD) test system
§
862.3590
Meprobamate test system
§
862.3600
Mercury test system
§
862.3610
Methamphetamine test system
§
862.3620
Methadone test system
§
862.3630
Methaqualone test system
§
862.3640
Morphine test system
§
862.3645
Neuroleptic drugs radioreceptor assay test system
§
862.3650
Opiate test system
§
862.3652
Organophosphate test system
§
862.3660
Phenobarbital test system
§
862.3700
Propoxyphene test system
§
862.3750
Quinine test system
§
862.3800
Reagents for molecular diagnostic instrument test systems
§
862.3830
Salicylate test system
§
862.3840
Sirolimus test system
§
862.3850
Sulfonamide test system
§
862.3870
Cannabinoid test system
§
862.3880
Theophylline test system
§
862.3900
Tobramycin test system
§
862.3910
Tricyclic antidepressant drugs test system
§
862.3950
Vancomycin test system